Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Therapeutic Advances in Gastroenterology
|
October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis
Marc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
Inflammatory Bowel Diseases
|
November 18, 2021
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment
David Busquets, Lia Oliver, Joan Amoedo, et al.
Journal of Crohn'S & Colitis
|
March 1, 2018
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial
Eugeni Domènech, Julián Panés, Joaquín Hinojosa, et al.
Cancers
|
November 21, 2020
Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals
Nuria Dueñas, Matilde Navarro, Àlex Teulé, et al.
Cancers
|
July 2, 2021
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. <i>Cancers</i> 2020, <i>12</i>, 3419
Nuria Dueñas, Matilde Navarro, Àlex Teulé, et al.
Journal of Crohn'S & Colitis
|
October 6, 2017
Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis
Núria Planell, M Carme Masamunt, Raquel Franco Leal, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
March 9, 2019
The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study
Ana Echarri, Isabel Vera, Virginia Ollero, et al.
Plos One
|
October 10, 2025
Correction: New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
Marta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
International Journal of Molecular Sciences
|
December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease
Marisa Iborra, Inés Moret, Enrique Busó, et al.
Plos One
|
December 1, 2020
New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
Marta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Therapeutic Advances in Gastroenterology
|
October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis
Marc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
Inflammatory Bowel Diseases
|
November 18, 2021
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment
David Busquets, Lia Oliver, Joan Amoedo, et al.
Journal of Crohn'S & Colitis
|
March 1, 2018
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial
Eugeni Domènech, Julián Panés, Joaquín Hinojosa, et al.
Cancers
|
November 21, 2020
Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals
Nuria Dueñas, Matilde Navarro, Àlex Teulé, et al.
Cancers
|
July 2, 2021
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. <i>Cancers</i> 2020, <i>12</i>, 3419
Nuria Dueñas, Matilde Navarro, Àlex Teulé, et al.
Journal of Crohn'S & Colitis
|
October 6, 2017
Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis
Núria Planell, M Carme Masamunt, Raquel Franco Leal, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
March 9, 2019
The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study
Ana Echarri, Isabel Vera, Virginia Ollero, et al.
Plos One
|
October 10, 2025
Correction: New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
Marta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
International Journal of Molecular Sciences
|
December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease
Marisa Iborra, Inés Moret, Enrique Busó, et al.
Plos One
|
December 1, 2020
New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
Marta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
Page
of 12